藥物動力學/毒性研究

ADME/Tox 線上系列講座

November 14, 2012
One of these is Not Like the Other: a Comparison of USFDA and EMA Guidance in the Conduct of Enzyme Induction Studies In Vitro
Speaker: David Stresser , Ph.D., Program Manager, BD Gentest™ Contract Research Services, BD Biosciences
Time: 11:00 AM EST
View now »
 

January 30, 2013
Recombinant Enzymes as a Model System for Drug Profiling Studies
Speaker: Christopher Patten, Ph.D., Program Manager / R&D, BD Biosciences
Time: 11:00 AM EST
View now » 
 

February 13, 2013
CYP Activity Levels in Human Livers: Trends and Impact on Designing Pooled Human Liver Microsome Reagents for Metabolic Stability, CYP Inhibition and Reaction Phenotyping
Speaker: Charlie Crespi, Ph.D., Vice President - Discovery Labware, BD Biosciences
Time: 11:00 AM EST
View now » 
 

March 13, 2013
Evaluation of mRNA and Enzyme Activity: EC50 and Emax as Endpoints in Human Hepatocyte Induction Studies to Predict Clinical Inducers and Non-inducers of CYP3A4
Speaker: George Zhang, Ph.D., Study Director, BD Biosciences
Time: 11:00 AM EST
Register now »
 

April 17, 2013
Overview of In Vitro Methods for Studying Drug Glucuronidation
Speaker: Christopher Patten, Ph.D., Program Manager / R&D, BD Biosciences
Time: 11:00 AM EST
Register now »
 

May 15, 2013
In Vitro ABC Transporter Models and Alignment with USFDA and EMA Guidelines (part 1 of 2)
Speaker: Na Li, Ph.D., Staff Scientist / R&D, BD Biosciences
Time: 11:00 AM EST

 

June 12, 2013
In Vitro SLC Transporter Models and Alignment with USFDA and EMA Guidelines (part 2 of 2)
Speaker: Na Li, Ph.D., Staff Scientist / R&D, BD Biosciences
Time: 11:00 AM EST